ARTICLE SUMMARY:
For more than 100 years, measuring hypertension has been an essential component of basic medical treatment. Yet, despite known inadequacies, the way in which blood pressure is measured has remained largely unchanged. Nueon is looking to update this process using a novel point-of-care blood test that could change the patient care paradigm.
Treating hypertension, particularly in patients resistant to drug therapy, has been a hot topic in the medical device industry over the past few years, driven largely by the development of myriad renal denervation (RDN) technologies to address this patient population.
